ArticleOncotarget2017

A retrospective clinical study of comparing paclitaxel plus S-1 versus paclitaxel plus cisplatin as the first-line treatment for patients with advanced esophageal squamous cell carcinoma.

Hai-Ying Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.